Amyl Therapeutics
Description: Amyl Therapeutics develops novel therapies for protein misfolding diseases, aiming to transform treatment for systemic amyloidosis patients.
Country: Belgium
Based in: Liege
Founded: 2020
Funding Stage: Pre-Seed
Tags: ['Biotechnology', 'Health Care', 'Life Science', 'Medical']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
